Question 1

What product names did capAI demonstrate in its AI-assisted authoring webinar on 12 June 2026?

Accepted Answer

On 12 June 2026, capAI held a live product webinar demonstrating AI-assisted authoring with Author42, AI-generated cinematic trailers with Movie42, and browser-based game creation with Gamers42.

Question 2

What decision point and IP cost did capAI face at the capMedia common licence expiry period from 8 July 2026 to 7 July 2027?

Accepted Answer

Between 8 July 2026 and 7 July 2027, capAI faced a decision at the capMedia licence expiry on whether to exercise £2m-per-platform IP purchase options or let licences lapse.

Question 3

Why did capAI describe the Ageotype licence and option agreement with R42 Group as a related party transaction?

Accepted Answer

capAI said the Ageotype licence and option agreement with R42 Group is a related party transaction under DTR 7.3 because R42 is led by capAI’s Executive Chairman, Professor Ronjon Nag.

Question 4

What licence and option terms does capAI have for Ageotype with R42 Group?

Accepted Answer

On 23 July 2026, capAI received an exclusive worldwide licence to develop and commercialise Ageotype with a discretionary option to acquire the underlying IP for £2.0m; the licence runs 12 months from signing to 22 July 2027.

Question 5

What expiry date were the Author42, Movie42 and Gamers42 licence and option agreements aligned to in July 2026?

Accepted Answer

On 8 July 2026, the Author42, Movie42 and Gamers42 licence and option agreements were amended and extended so their licences all expire on 7 July 2027.

Question 6

What is R42 Group entitled to receive under the Ageotype agreement if capAI monetises it after exercising the option?

Accepted Answer

Under the 23 July 2026 Ageotype licence and option agreement, R42 is entitled to 20% of net proceeds from any future monetisation if and once the option is exercised.

Timeline

capAI

capAI licenses Ageotype platform from R42 for capMedical launch

Capai extends runway for three AI media platforms

capAI launches Movie42 and Gamers42 betas and moves capMedia into commercial evaluation

capAI takes Game42 and Movie42 live

More in AI & Machine Learning

IP Group leads £4m funding round for AI materials spin-out

Oxford Metrics buys Move AI assets to widen Vicon's markerless capture

MedPal AI confirms no equity raise planned as it seeks working capital facility

Tekcapital's Innovative Eyewear launches lightest-ever smart glasses line

Built Cybernetics agrees Ecolibrium acquisition with £3m fundraise

Property Franchise Group takes 25% stake in AI platform Enteka

Cybersecurity specialist Chaleit joins AIM after £2.1m fundraise

Quantum Blockchain secures US patent grant for ASIC Ultra Boost

Hostelworld says higher travel costs weighing on customer bookings

Health & Bio Today: Avacta, Cambridge Cognition, MedPal AI, Smith+Nephew, Poolbeg Pharma, OKYO Pharma

MedPal AI revenue run rate boosted by repeat orders

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer